Screener
Amgen AMGN Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Amgen’s reported figures.
Based on the most recent quarter.
The source filing: Amgen’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 7:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000318154-26-000057
FAQ
- What is Amgen's debt-to-equity?
- Amgen (AMGN) reported debt-to-equity of 6.2× in Q1 2026.
- How has Amgen's debt-to-equity changed year-over-year?
- Amgen's debt-to-equity decreased by 32.5% year-over-year, from 9.2× to 6.2×.
- What is the long-term trend for Amgen's debt-to-equity?
- Over 5 years (2020 to 2025), Amgen's debt-to-equity has grown at a 12.5% compound annual growth rate (CAGR), from 3.6× to 6.4×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Amgen's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude